Edap Tms (EDAP) Return on Equity (2025 - 2026)
Edap Tms (EDAP) reported Return on Equity of 0.02% for Q1 2026, down 2.0% on a YoY basis from 0.02% in Q1 2025, and down 278.68% quarter-over-quarter from 0.01% in Q1 2025.
Edap Tms (EDAP) Return on Equity (2025 - 2026) Analysis & Trends
Edap Tms has reported Return on Equity for 2 years, with the latest figure at 0.02% in Q1 2026.
- For the quarter ending Q1 2026, Return on Equity fell 2.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (down 2.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
- Return on Equity for Q1 2026 stood at 0.02%, down from 0.01% in the prior quarter.
- The five-year high for Return on Equity was 0.01% in Q1 2025, with the low at 0.02% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -0.04% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 0.01% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -0.01% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 0.00% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 0.02% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -0.02% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 0.00% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -0.01% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Mar 31, 2025 | -0.01% |